azomycin has been researched along with Central Nervous System Diseases in 9 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 7 (77.78) | 18.7374 |
1990's | 1 (11.11) | 18.2507 |
2000's | 1 (11.11) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Gangji, D; Koziol, D; Partington, J; Phillips, TL; Schwade, JG; Strong, JM; Urtasun, R; Van Raalte, G; Wasserman, TH | 1 |
Johnson, RJ; Levin, VA; Phillips, TL; VanRaalte, G; Wasserman, TH | 1 |
Jennings, FW; Miller, BM; Murray, PK; Urquhart, GM | 2 |
Jokipii, AM; Jokipii, L | 1 |
Goldin, B; Sullivan, NE; Tally, FP | 1 |
Jennings, FW | 1 |
Hokkanen, E; Jokipii, AM; Jokipii, L; Myllylä, VV | 1 |
1 review(s) available for azomycin and Central Nervous System Diseases
Article | Year |
---|---|
Combination chemotherapy of CNS trypanosomiasis.
Topics: Arsenicals; Central Nervous System Diseases; Drug Therapy, Combination; Humans; Melarsoprol; Nitroimidazoles; Trypanocidal Agents; Trypanosomiasis, African | 1993 |
8 other study(ies) available for azomycin and Central Nervous System Diseases
Article | Year |
---|---|
Chagas disease: the forgotten American neuroinfection.
Topics: Americas; Central Nervous System Diseases; Chagas Disease; History, 20th Century; History, 21st Century; Humans; Nifurtimox; Nitroimidazoles; Trypanocidal Agents | 2009 |
The neurotoxicity of misonidazole: potential modifying role of phenytoin sodium and dexamethasone.
Topics: Central Nervous System Diseases; Dexamethasone; Drug Interactions; Half-Life; Humans; Misonidazole; Nitroimidazoles; Peripheral Nervous System Diseases; Phenytoin | 1980 |
Final report on the United States Phase I Clinical Trial of the hypoxic cell radiosensitizer, misonidazole (Ro-07-0582; NSC #261037).
Topics: Adolescent; Adult; Aged; Central Nervous System Diseases; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Evaluation; Female; Hearing Loss; Humans; Male; Middle Aged; Misonidazole; Nausea; Nitroimidazoles; Peripheral Nervous System Diseases; Vomiting | 1981 |
Treatment with suramin and 2-substituted 5-nitroimidazoles of chronic murine Trypanosoma brucei infections with central nervous system involvement.
Topics: Animals; Antiprotozoal Agents; Cattle; Central Nervous System Diseases; Drug Therapy, Combination; Female; Mice; Nitroimidazoles; Suramin; Trypanosoma brucei brucei; Trypanosomiasis, African | 1983 |
Metronidazole, tinidazole, ornidazole and anaerobic infections of the middle ear, maxillary sinus and central nervous system.
Topics: Bacterial Infections; Central Nervous System Diseases; Humans; Maxillary Sinus; Metronidazole; Nitroimidazoles; Ornidazole; Otitis Media; Sinusitis; Tinidazole | 1981 |
Nitroimidazoles: in vitro activity and efficacy in anaerobic infections.
Topics: Anaerobiosis; Bacteria; Bacterial Infections; Central Nervous System Diseases; Female; Genital Diseases, Female; Humans; Microbial Sensitivity Tests; Nitroimidazoles; Respiratory Tract Infections | 1981 |
'Berenil' and nitroimidazole combinations in the treatment of Trypanosoma brucei infection with central nervous system involvement.
Topics: Amidines; Animals; Benzamidines; Central Nervous System Diseases; Diminazene; Ethidium; Female; Isoxazoles; Mice; Nitroimidazoles; Phenanthridines; Ronidazole; Time Factors; Trypanocidal Agents; Trypanosoma brucei brucei; Trypanosomiasis, African | 1980 |
Penetration of the blood brain barrier by metronidazole and tinidazole.
Topics: Animals; Bacterial Infections; Bacteroides Infections; Blood-Brain Barrier; Central Nervous System Diseases; Female; Fusobacterium Infections; Humans; Male; Metronidazole; Nitroimidazoles; Rabbits; Time Factors; Tinidazole | 1977 |